Neuron23

Neuron23 is a clinical-stage biotechnology company developing precision medicines for Parkinson’s disease driven by hyperactive LRRK2.

Biotechnology Research

Explore the company ↓Explore its lists ↓

Headquarters: South San Francisco, California, United StatesSource: RevenueBaseRetrieved October 13, 2026
Employee range: 11 to 50Source: RevenueBaseRetrieved October 13, 2026
Founded: 2018Source: RevenueBaseRetrieved October 13, 2026
Published list appearances: 2 supported appearances ↗Source: RevenueBase lists

The company at a glance

What does Neuron23 do?

The company combines human genetics, drug discovery and biomarker platforms, machine learning, and artificial intelligence. Founded in 2018, Neuron23 has a team of experts and entrepreneurs in South San Francisco, California.

Based on the company’s public LinkedIn information, supplied through RevenueBase.

What the business offers

Services & capabilities.

Precision medicine development

The company develops medicines for Parkinson’s disease driven by hyperactive LRRK2.

Source: LinkedIn company description · Retrieved October 13, 2026

Drug discovery and biomarker platform

The company combines its drug discovery and biomarker platform with advances in human genetics.

Source: LinkedIn company description · Retrieved October 13, 2026

Explore the business in context

Company lists.

Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.

#8OF 25

United States

Parkinson's disease treatment companies

Snapshot: September 19, 2026

↗

#15OF 25

Worldwide

Parkinson's disease treatment companies

Snapshot: September 19, 2026

↗

Positions describe ordering within each source list. See how lists are built ↗

Share your recognition

Embeddable award for your website

BADGE PREVIEW

Open the published source list.

Neuron23

#8 Parkinson's disease treatment companies

Snapshot: September 19, 2026

Display size

Download SVG

Copy this code into your website

<a href="https://revenuebase.ai/companies/parkinson-s-disease-treatment-companies/united-states" target="_blank" rel="nofollow noopener">
  <img src="https://revenuebase.ai/companies/profiles/neuron23/recognition-companies-parkinson-s-disease-treatment-companies-united-states-20260920-bd9db6d1275f8455a462e7cfb3902fdb94db679ff4aeb7c78fa298494c1638ef.svg" alt="Neuron23 listed #8 on Parkinson&#x27;s disease treatment companies, September 19, 2026" width="220" height="319" style="max-width:100%;height:auto;" />
</a>

View live list ↗

Sources & data notes.

RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 4, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 19, 2026. How the company lists are built.

Help keep this profile accurate

Something changed?

Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.

Request an update ↗

Find your next account

One company is just the start.

Explore more companies by name, headquarters and business focus.

Explore company profiles →